Navigation Links
Treatment not testicular cancer poses greatest risk to survivors' long-term health
Date:10/15/2009

than 10 per cent use their frozen samples later on.

  • Pulmonary complications can arise in men who receive the drug bleomycin before larger surgical procedures, particularly if they are aged 40 or over.

  • Radiotherapy can cause short-term nausea, vomiting and lethargy, but side-effects tend to decrease two to four weeks after therapy.

  • Cisplatin-based chemotherapy can damage the sensory nerves in 10 to 30 per cent of patients and 20 per cent of survivors complain of impaired hearing and tinnitus.

  • Most acute drug toxicity problems tend to resolve themselves, or decrease, in the first year, but long-term problems pose greater issues. Despite this, many patients are only monitored by their consultant for five to ten years, after which they may or may not be regularly seen by primary care professionals.

  • Survivors are up to 1.8 times more likely to develop a secondary cancer, particularly solid malignancies below the diaphragm. The introduction of cisplatin-based chemotherapy, and a gradual reduction in radiotherapy, does not appear to have reduced the secondary cancer risk. But it appears to reduce the risk of cancer developing in the remaining testicle.

  • Avoiding mediastinal radiotherapy has reduced the risk of chronic heart complications, but death rates are still slightly increased by infra-diaphragmatic radiotherapy. In addition, the chemotherapy drug cisplatin can cause inflammation of the endothelial cells, leading to premature thickening of the coronary arteries.

  • About 20 per cent of survivors have already suffered irreversible hypogonadism, where the testes produces little or no sex hormone, and reduced fertility before their cancer is diagnosed.

  • Removal of lymph nodes in the abdomen can lead to dry ejaculation in some patients and infra-diaphragmatic radiotherapy and chemotherapy can cause temporary reductions in fertility.

  • Surprisingly, sur
    '/>"/>

  • Contact: Annette Whibley
    wizard.media@virgin.net
    Wiley-Blackwell
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Nicotinic receptors may be important targets for treatment of multiple addictions
    2. A new radiation therapy treatment developed for head and neck cancer patients
    3. Restoring sight, advances in fertility treatments and better visibility for pilots at FIO
    4. Presence of gene mutation helps guide thyroid cancer treatment
    5. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
    6. New genetic research into nicotine addiction shows promise for personalized treatment
    7. Interleukin-8, key marker for colorectal cancer treatment
    8. New class of drug offers hope to treatment-resistant AIDS patients
    9. Paradigm shift in Alzheimerss research: new treatments
    10. New research on structure of bones raises questions for treatment of osteoporosis
    11. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... Research and Markets( http://www.researchandmarkets.com/research/zj7h4f/latin_america ... America Biomedical Sensors Market - Growth, Trends & Forecasts ... Latin America Biomedical Sensors market is estimated at $0.65 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
    (Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
    (Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
    Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
    ... for the first time that genetic mutations in the ... in which muscle fibers do not function properly, resulting ... as well as skeletal muscles, and titin is responsible ... research was done by Danielle Buck, a doctoral candidate ...
    ... grass that has spread extensively in disturbed areas throughout ... fire hazard and inhibited reforestation efforts. The weed originally ... to the conditions in Panama and produces excessive amounts ... efforts. A new study published in the open access ...
    ... of a deadly pathogen,s family tree may have ended centuries ... lineage with links to the modern world. An international ... most devastating pandemicsthe plague of Justinian and the Black Death, ... in Europewere caused by distinct strains of the same pathogen. ...
    Cached Biology News:UA researchers find culprit behind skeletal muscle disease 2UA researchers find culprit behind skeletal muscle disease 3Effective control of invasive weeds can help attempts at reforestation in Panama 2Research uncovers historical rise, fall and re-emergence of plague strains 2Research uncovers historical rise, fall and re-emergence of plague strains 3
    (Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
    (Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
    (Date:7/29/2015)... Ala., July 29, 2015  HealthSouth ... nation,s largest providers of post-acute healthcare services, offering ... its results of operations for the second quarter ... quarter was characterized by strong volume growth in ... Adjusted EBITDA," said Jay Grinney, President and Chief ...
    (Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
    Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
    ... Calif., July 21 Abingdon Life Sciences,announces the ... The,offices, located at 5963 La Place Court, Suite ... to Palomar Airport. Abingdon Life Sciences,Inc. is a ... on providing drug and device companies with,superior services ...
    ... 11:00 a.m. ET; 8:00 a.m. PT, VANCOUVER and ... MGI; OTC: MGIFF), a clinical-stage developer of drugs for,infectious ... Monday,July 21, 2008 at 11:00 a.m. ET (8:00 a.m. ... and fiscal year ended April 30, 2008 and,provide an ...
    ... BioEnergy International, LLC,(BioEnergy), a privately-held, biotech-based developer ... announces the,acquisition of certain assets of OmniGene ... current employees. OBI, currently based in Cambridge,MA, ... technology,and metabolic pathway engineering expertise to develop ...
    Cached Biology Technology:Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 3
    ... The Bio-Rad Molecular Imager VersaDoc MP ... quantitative CCD based imaging system capable ... detection methods, including fluorescence, chemiluminescence, densitometry, ... Blue illumination sources allow imaging of ...
    ... barrier pen for immunohistochemistry and in situ ... or paraffin-embedded tissue sections mounted on glass ... water-repellent barrier that keeps staining reagents localized ... reagents when differentially staining two sections on ...
    ...
    ... The Infinite 200 series of microplate readers ... absorbance detection in an affordable, easy-to-use platform ... applications. The unique modular design and adaptability ... with a choice of a monochromator (M200) ...
    Biology Products: